New Insights into Cartilage Loss and Aging
Stanford University researchers have pinpointed a specific protein linked to cartilage loss in aging, which could open the door to treatments aimed at improving mobility and reducing discomfort in older adults.
The protein, 15-PGDH, has been associated with aging, increasing in prevalence as we grow older. It seems to obstruct molecules that are essential for tissue repair and inflammation reduction.
This connection has led scientists to investigate its role in osteoarthritis, a condition where joint stress contributes to collagen breakdown in cartilage, resulting in pain and inflammation.
In experiments with older mice, cartilage that had previously deteriorated showed signs of thickening when a 15-PGDH inhibitor was introduced. Similarly, young mice with injuries benefited from the inhibitor, which helped guard against the typical effects of injury-linked osteoarthritis.
When researchers induced an injury similar to an anterior cruciate ligament tear in mice and applied the treatment, osteoarthritis did not manifest, contrary to what is usually expected in these models.
Earlier efforts at regenerating cartilage often involved utilizing stem cells, but the need for them vanished with 15-PGDH inhibition. Instead, chondrocyte cells—responsible for cartilage maintenance—were rejuvenated, becoming healthier and more functional.
“It’s a fresh approach to regenerating adult tissue, holding considerable promise for treating arthritis related to age or injury,” says microbiologist Helen Blau. “We were searching for stem cells, but they don’t appear to play a role here. It’s thrilling.”
Treated mice exhibited improved mobility, suggesting reduced pain, and were putting more weight on injured legs—clear indicators that cartilage restoration led to better physical health.
Similar experiments were conducted using human tissue samples from knee replacement surgeries. The results showed significant regeneration, with cartilage appearing stiffer and exhibiting less inflammation.
“The mechanism is quite remarkable and really alters our understanding of how tissue regeneration can take place,” states orthopaedic scientist Nidhi Bhutani. “It’s evident that many existing cells in cartilage alter their gene expression patterns.”
“Targeting these cells for regeneration presents an opportunity for more significant clinical impacts,” Bhutani adds.
While there’s much more research ahead, this work could eventually result in effective treatments that mitigate damage from arthritis or aging. We may be moving toward a future where hip and knee replacements might be a thing of the past.
Current osteoarthritis treatments primarily focus on pain relief. Despite promising advancements recently, solutions tackling the underlying cause remain elusive.
Upcoming steps may include clinical trials. Previous studies involving a 15-PGDH blocker to treat muscle weakness raised no health concerns, which could expedite trials for similar medications.
“We are very excited about this potential breakthrough,” Blau notes. “Just imagine the possibility of regrowing existing cartilage and avoiding joint replacements altogether.”
This research has been published in Science.
